ID 208216107 · FY 2017–2024 · 8 years
Pharmaceutical manufacturer and part of the Aversi pharma group, one of Georgia's largest pharmacy chains.
curated 2026-06-03reportal.geaversi.ge
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31,294 | 22,626 | 33,693 | 39,215 | 51,337 | 58,499 | 59,765 | 63,771 | +10.7% |
| Total COGS | -17,423 | -14,004 | -21,026 | -25,038 | -33,746 | -38,392 | -35,022 | -36,548 | +11.2% |
| Gross Profit | 13,871 | 8,623 | 12,666 | 14,177 | 17,591 | 20,108 | 24,744 | 27,223 | +10.1% |
| Gross Margin | 44.3% | 38.1% | 37.6% | 36.2% | 34.3% | 34.4% | 41.4% | 42.7% | |
| Total Operating Expenses | -11,360 | -12,140 | -10,490 | -10,362 | -13,286 | -14,052 | -15,731 | -15,856 | +4.9% |
| EBITDA | 2,511 | -3,518 | 2,177 | 3,815 | 4,305 | 6,055 | 9,013 | 11,367 | +24.1% |
| EBITDA Margin | 8.0% | -15.5% | 6.5% | 9.7% | 8.4% | 10.4% | 15.1% | 17.8% | |
| Total D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT / Operating Income | 2,511 | -3,518 | 2,177 | 3,815 | 4,305 | 6,055 | 9,013 | 11,367 | +24.1% |
| Total Interest Income | 237 | 98 | 169 | 199 | 185 | 172 | 118 | 82 | -14.0% |
| Total Interest Expense | 0 | 0 | -210 | -191 | -184 | -177 | -168 | -159 | -5.4% |
| Total Other Income | 0 | 219 | 285 | 461 | -244 | -375 | -247 | 193 | -2.1% |
| Profit Before Tax | 2,748 | -3,201 | 2,419 | 4,284 | 4,062 | 5,676 | 8,715 | 11,483 | +22.7% |
| Total Income Tax | 0 | -19 | -222 | -53 | 0 | -44 | -34 | -1,018 | +94.2% |
| Net Profit / (Loss) | 2,231 | -3,903 | 2,441 | 4,231 | 4,062 | 5,632 | 8,680 | 10,465 | +24.7% |
| Net Margin | 7.1% | -17.2% | 7.2% | 10.8% | 7.9% | 9.6% | 14.5% | 16.4% |
Ownership & directors from companyinfo.ge (public corporate registry).